Croatia vs Ireland: Reported rate of new cervical cancer cases
Croatia
9.86 per 100,000 women
in 2017
Ireland
9.63 per 100,000 women
in 2017
Croatia rank
15th
Ireland rank
17th
Reported rate of new cervical cancer cases over time
- Croatia
- Ireland
How they compare
Croatia currently reports 9.86 per 100,000 women against 9.63 per 100,000 women in Ireland, a difference of 0.23 per 100,000 women.
The two have swapped places 4 times across 24 shared years of data; in 1994 it was Croatia ahead.
Croatia ranks 15th and Ireland ranks 17th of 46 countries.
Croatia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Croatia | Ireland | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 12 per 100,000 women | 8.41 per 100,000 women | 3.59 per 100,000 women | Croatia |
| 2000s | 11.17 per 100,000 women | 9.38 per 100,000 women | 1.79 per 100,000 women | Croatia |
| 2010s | 10.08 per 100,000 women | 9.98 per 100,000 women | 0.0962 per 100,000 women | Croatia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher reported rate of new cervical cancer cases, Croatia or Ireland?
- Croatia, at 9.86 per 100,000 women against 9.63 per 100,000 women in Ireland as of 2017.
- What is the difference in reported rate of new cervical cancer cases between Croatia and Ireland?
- 0.23 per 100,000 women, with Croatia ahead.
- How many years of comparable data are there for Croatia and Ireland?
- 24 years are reported by both, from 1994 to 2017.
- How do Croatia and Ireland rank globally for reported rate of new cervical cancer cases?
- Croatia ranks 15th and Ireland ranks 17th of 46 countries.
- Where does this data come from?
- Global Cancer Observatory (2025) – processed by Our World in Data, published as Reported rate of new cervical cancer cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Reported number of new cervical cancer cases per 100,000 women, based on data from cancer registries. Comparisons may be affected by differences in measurement, including screening and diagnosis.